Granulin-epithelin precursor as a therap
โ
Jenny C. Ho; Ying Chi Ip; Siu Tim Cheung; Yuk Ting Lee; Kui Fat Chan; San Yu Won
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 823 KB
Primary liver cancer, hepatocellular carcinoma (HCC), is the fifth most common cancer and the third leading cancer killer in the world. There is no effective therapeutic option for most HCC patients. A new therapeutic strategy is essential. Granulin-epithelin precursor (GEP, also called progranulin,